These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23898821)

  • 41. Identification and quantitation of signal molecule-dependent protein phosphorylation.
    Groen A; Thomas L; Lilley K; Marondedze C
    Methods Mol Biol; 2013; 1016():121-37. PubMed ID: 23681576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Technologies and challenges in large-scale phosphoproteomics.
    Engholm-Keller K; Larsen MR
    Proteomics; 2013 Mar; 13(6):910-31. PubMed ID: 23404676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative measurement of phosphopeptides and proteins via stable isotope labeling in Arabidopsis and functional phosphoproteomic strategies.
    Li N
    Methods Mol Biol; 2012; 876():17-32. PubMed ID: 22576083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC).
    Amanchy R; Kalume DE; Iwahori A; Zhong J; Pandey A
    J Proteome Res; 2005; 4(5):1661-71. PubMed ID: 16212419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of Parameters for Confident Phosphorylation Site Localization Using an Orbitrap Fusion Tribrid Mass Spectrometer.
    Ferries S; Perkins S; Brownridge PJ; Campbell A; Eyers PA; Jones AR; Eyers CE
    J Proteome Res; 2017 Sep; 16(9):3448-3459. PubMed ID: 28741359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Advances in analysis techniques of phosphoproteome].
    Yang J; Zou QM; Cai SX; Guo G; Zhu YH
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):244-8. PubMed ID: 15966331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphoproteomics Meets Chemical Genetics: Approaches for Global Mapping and Deciphering the Phosphoproteome.
    Jurcik J; Sivakova B; Cipakova I; Selicky T; Stupenova E; Jurcik M; Osadska M; Barath P; Cipak L
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insights from site-specific phosphoproteomics in bacteria.
    Soufi B; Jers C; Hansen ME; Petranovic D; Mijakovic I
    Biochim Biophys Acta; 2008 Jan; 1784(1):186-92. PubMed ID: 17881301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proteome-Wide Quantitative Phosphoproteomic Analysis of Trypanosoma brucei Insect and Mammalian Life Cycle Stages.
    Benz C; Urbaniak MD
    Methods Mol Biol; 2020; 2116():125-137. PubMed ID: 32221919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphoproteomics in analyzing signaling pathways.
    Mukherji M
    Expert Rev Proteomics; 2005 Jan; 2(1):117-28. PubMed ID: 15966857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathways.
    Kosako H; Nagano K
    Expert Rev Proteomics; 2011 Feb; 8(1):81-94. PubMed ID: 21329429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Broader implications of SILAC-based proteomics for dissecting signaling dynamics in cancer.
    Zhang H; Xu Y; Papanastasopoulos P; Stebbing J; Giamas G
    Expert Rev Proteomics; 2014 Dec; 11(6):713-31. PubMed ID: 25345469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of HER family signaling as a mechanism of acquired resistance to ALK inhibitors in EML4-ALK-positive non-small cell lung cancer.
    Tanizaki J; Okamoto I; Okabe T; Sakai K; Tanaka K; Hayashi H; Kaneda H; Takezawa K; Kuwata K; Yamaguchi H; Hatashita E; Nishio K; Nakagawa K
    Clin Cancer Res; 2012 Nov; 18(22):6219-26. PubMed ID: 22843788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analytical strategies in mass spectrometry-based phosphoproteomics.
    Rosenqvist H; Ye J; Jensen ON
    Methods Mol Biol; 2011; 753():183-213. PubMed ID: 21604124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of the PLK2-dependent phosphopeptidome by quantitative proteomics [corrected].
    Franchin C; Cesaro L; Pinna LA; Arrigoni G; Salvi M
    PLoS One; 2014; 9(10):e111018. PubMed ID: 25338102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Super-SILAC mix coupled with SIM/AIMS assays for targeted verification of phosphopeptides discovered in a large-scale phosphoproteome analysis of hepatocellular carcinoma.
    Lin YT; Chien KY; Wu CC; Chang WY; Chu LJ; Chen MC; Yeh CT; Yu JS
    J Proteomics; 2017 Mar; 157():40-51. PubMed ID: 28192239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling.
    Huang FK; Zhang G; Lawlor K; Nazarian A; Philip J; Tempst P; Dephoure N; Neubert TA
    J Proteome Res; 2017 Mar; 16(3):1121-1132. PubMed ID: 28102081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in the analysis of protein phosphorylation.
    Paradela A; Albar JP
    J Proteome Res; 2008 May; 7(5):1809-18. PubMed ID: 18327898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PhosphoPath: Visualization of Phosphosite-centric Dynamics in Temporal Molecular Networks.
    Raaijmakers LM; Giansanti P; Possik PA; Mueller J; Peeper DS; Heck AJ; Altelaar AF
    J Proteome Res; 2015 Oct; 14(10):4332-41. PubMed ID: 26317507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mass spectrometric-based quantitative proteomics using SILAC.
    Lanucara F; Eyers CE
    Methods Enzymol; 2011; 500():133-50. PubMed ID: 21943896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.